Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers
暂无分享,去创建一个
K. Chìn | Hitoshi Sato | Masataka Tajima | D. Takahari | T. Ichimura | K. Yamaguchi | T. Wakatsuki | E. Sugiyama | T. Yokokawa | T. Hama | E. Shinozaki | M. Ogura | Kenichi Suzuki | Y. Minowa | Y. Nakano | M. Suenaga | K. Kawakami | T. Aoyama | W. Suzuki | A. Ooki | I. Nakayama | K. Kobayashi | H. Kidokoro | Koki Hashimoto | T. Hiraoka | K. Chin